APA

Daste A., de Mones E., Digue L., François L., Domblides C., Dupin C., Bigourdan A. & Ravaud A. (20181024). Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatment. : Oral oncology.

Chicago

Daste Amaury, de Mones Erwan, Digue Laurence, François Louis, Domblides Charlotte, Dupin Charles, Bigourdan Antoine and Ravaud Alain. 20181024. Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatment. : Oral oncology.

Harvard

Daste A., de Mones E., Digue L., François L., Domblides C., Dupin C., Bigourdan A. and Ravaud A. (20181024). Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatment. : Oral oncology.

MLA

Daste Amaury, de Mones Erwan, Digue Laurence, François Louis, Domblides Charlotte, Dupin Charles, Bigourdan Antoine and Ravaud Alain. Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatment. : Oral oncology. 20181024.